Glanbia plc (GLAPF)
- Previous Close
11.25 - Open
11.25 - Bid 12.92 x 43500
- Ask 14.24 x 38500
- Day's Range
11.25 - 11.25 - 52 Week Range
11.25 - 20.00 - Volume
100 - Avg. Volume
47 - Market Cap (intraday)
3.34B - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
19.42 - EPS (TTM)
0.62 - Earnings Date Aug 12, 2025 - Aug 18, 2025
- Forward Dividend & Yield 0.44 (3.62%)
- Ex-Dividend Date Mar 20, 2025
- 1y Target Est
--
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; and provision of business services and management solutions, weight management, flavor solutions, and bioactive solutions. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
www.glanbia.com5,791
Full Time Employees
January 04
Fiscal Year Ends
Sector
Industry
Recent News: GLAPF
View MorePerformance Overview: GLAPF
Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is ISEQ All Share (^ISEQ) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GLAPF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GLAPF
View MoreValuation Measures
Market Cap
3.40B
Enterprise Value
3.94B
Trailing P/E
19.28
Forward P/E
9.25
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
1.48
Enterprise Value/Revenue
1.03
Enterprise Value/EBITDA
8.68
Financial Highlights
Profitability and Income Statement
Profit Margin
4.29%
Return on Assets (ttm)
6.45%
Return on Equity (ttm)
7.83%
Revenue (ttm)
3.84B
Net Income Avi to Common (ttm)
164.7M
Diluted EPS (ttm)
0.62
Balance Sheet and Cash Flow
Total Cash (mrq)
417M
Total Debt/Equity (mrq)
46.26%
Levered Free Cash Flow (ttm)
297.19M